Biller Jonathan — SEC Form 4 filings
SEC reporting owner CIK 1744749. 14 Form 4 filings on record with FilingPulse; latest filed 2026-02-26.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-02-08 to 2026-02-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 10 filings — 16,446 shares, $7,598,215 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 3,433 shares @ $459.87 ($1,578,734) in VERTEX PHARMACEUTICALS INC / MA, filed 2025-02-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP and Chief Legal Officer | 14 | — | 11 legs · 16,446 sh · $7,598,215 | 16 |
Form 4 filings — Biller Jonathan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 1,144 @ $485.11 · Sale (S): 945 @ $486.35 | EDGAR |
| 2026-02-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 4,135 @ $0 · Tax withholding (F): 1,505 @ $483.75 · Sale (S): 2,476 @ $489.46 · Sale (S): 1,244 @ $473.68 | EDGAR |
| 2026-02-18 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 2,993 @ $487.76 · Sale (S): 988 @ $499 | EDGAR |
| 2026-02-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 1,630 @ $468.41 · Sale (S): 1,925 @ $460.43 | EDGAR |
| 2026-01-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 6,294 @ $0 · Grant/award (A): 2,774 @ $0 | EDGAR |
| 2025-12-05 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 347 @ $449 | EDGAR |
| 2025-10-03 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 1,259 @ $400 · Sale (S): 694 @ $404.21 | EDGAR |
| 2025-02-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 1,504 @ $463.46 · Sale (S): 1,657 @ $455.06 | EDGAR |
| 2025-02-14 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 4,437 @ $0 | EDGAR |
| 2025-02-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 1,632 @ $467.98 · Sale (S): 3,433 @ $459.87 | EDGAR |
| 2025-02-06 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 4,744 @ $0 | EDGAR |
| 2024-10-03 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 630 @ $466.84 · Sale (S): 999 @ $461.66 | EDGAR |
| 2024-02-13 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 1,588 @ $422.74 · Sale (S): 1,738 @ $418.77 | EDGAR |
| 2024-02-08 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 6,294 @ $0 · Grant/award (A): 4,743 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1744749 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →